InspireMD (NSPR) Misses Q2 EPS by 2c

InspireMD (NYSE: NSPR) reported Q2 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $540 thousand versus the consensus estimate of $800 thousand.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Revelation Biosciences (REVB) Misses Q2 EPS by 4c